HIV infection: Oral lesions, CD4+ cell count and viral load in an italian study population

Journal of Oral Pathology and Medicine

Volumn 28, Issue 4, 1999, Pages 173-177

  Margiotta, Valerio ^a,c   Campisi, G ^a   Mancuso, S ^b   Accurso, V ^b   Abbadessa, V ^b   Giaccone, Policlinico ^c  

^a Department of Oral Medicine ^*  (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c Istituto di Odontostomatologia   (Italy)

Author keywords

CD4+; HIV infection; HIV related oral lesions; Viral load

Indexed keywords

EID: 0033119976     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1999.tb02019.x     Document Type: Article

References (37)

1. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946-54.
2. PERELSON A, ESSUNGER Y, CAO Y, et al. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature 1997; 387:188-91.
3. MONIACI D, GRECO D, FLECCHIA G, RAITERI R, SINICCO A. Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions. J Oral Pathol Med 1990; 19:477-81.
4. FEIGAL DW, KATZ MH, GREENSPAN D, et al. The prevalence of oral lesions in HIV-infected homosexuals and bisexual men: three San Francisco epidemiological cohorts. AIDS 1991; 5:519-25.
5. LASKARIS G, HADJIVASSILIOU M, STRATIGOS J. Oral signs and symptoms in 160 Greek HIV infected patients. J Oral Pathol Med 1992; 21:120-31.
6. GLICK M. Evaluation of prognosis and survival of the HIV-infected patients. Oral Surg Oral Med Oral Pathol 1992; 74:386-92.
7. GLICK M, MUZYKA BC, LURIE D, SALKIN LM, CAMDEN NJ. Oral manifestations associated with related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994; 77:344-9.
8. KOLOKOTRONIS A, KIOSES V, ANTONIADES D, MANDRAVELI K, DOUTSOS I, PAPANAYOTOU P. Invmunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia. Oral Surg Oral Med Oral Pathol 1994; 78:41-6.
9. LAMSTER IB, BEGG MD, MITCHELL-LEWIS D, et al. Oral manifestations of HIV infection in homosexual men and intravenous drug users. Oral Surg Oral Med Oral Pathol 1994; 78:163-74.
10. CEBALLOS-SALOBREǸA, AGUIRRE-URIZAR JM, BAGAN-SEBASTIAN JV. Oral manifestations associated with human immunodeficiency virus infection in a Spanish population. J Oral Pathol Med 1996; 25:523-6.
11. BEGG M, PANAGEAS KS, MITCHELL-LEWIS D, BUKLAN RS, PHELAN JA, LAMSTER IB. Oral lesions as markers of severe immunosuppression in HIV-infected homosexual men and injection drug users. Oral Surg Oral Med Oral Pathol 1996; 82:276-83.
12. GREENSPAN D, GREENSPAN JS. HlV-related oral disease. Lancet 1996; 348: 729-33.
13. GREENSPAN JS. Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease. Oral Dis 1997; 3: suppl. (1):S13-7.
14. MIROWSKI GW, HILTON JF, GREENSPAN D, et al. Association of cutaneous and oral diseases in HIV-infected men. Oral Dis 1998; 4: 16-21.
15. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Center on Oral Manifestations of the Immunodeficiency Virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993; 22:289-91.
16. CARPENTER CC, FISCHL MA, HAMMER SM, et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations of International AIDS Society-USA Panel. JAMA 1997; 277:1962-9.
17. WHO. Building the capacity for an oral health response to the global HIV pandemic: principles for developing a country-specific approach. Geneva: WHO, 1995.
18. WHO. A guide for epidemiological studies of oral manifestations of HIV infection. Geneva: WHO, 1993.
19. SAAG M, HOODNLY M, KURITZKES D. HIV viral load markers in clinical practice. Nat Med 1996; 2:625-9.
20. SCHULTEN EAJM, TEN KATE RW, VAN DER WAAL I, et al. Oral manifestations of HIV infection in 75 Dutch patients. J Oral Pathol Med 1989; 18:42-6.
21. WEINERT M, GRIMES RM, LYNCH DP. Oral manifestations of HIV infection. Ann Intern Med 1996; 125:485-96.
22. BARR CE, LOPEZ MR, RUA-DOBLES A, MILLER LK, MATHUR-WAGH U, TURGEON LR. HIV-associated oral lesions: immunologic, virologic and salivary parameters. J Oral Pathol Med 1990; 21:295-8.
23. FARIZO DW, KATZ MH, GREENSPAN D. et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992; 267:1798-805.
24. MALONE JL, SIMMS TE, GRAY GC, et al. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr 1990; 3:144-51.
25. BEGG MD, LAMSTER IB, PANAGEAS KS, MITCHELL-LEWIS D, PHELAN JA, GRBIC JT. A prospective study of oral lesions and their predictive value for progression of HIV disease. Oral Dis 1997; 3:176-83.
26. NIELSEN H, BENTSEN KD, HOØJTVED L, et al. Oral candidiasis and immune status of HIV-infected patients. J Oral Pathol Med 1994; 23:140-3.
27. TRIANTOS D, PORTER SR, SCULLY C, TEO CG. Oral hairy leukoplakia: clinicopathologic features, pathogenesis, diagnosis and clinical significance, Clin Infect Dis 1997; 25:1392-6.
28. KATZ MH, GREENSPAN D, WESTENHOUSE J, et al. Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS 1992; 6: 95-100.
29. ROYCE RA, LUCKMANN RS, FUSARO RE, WINKELSTEIN JR. W. The natural history of HIV-1 infection: staging classifications of disease. AIDS 1991; 5: 355-64.
30. JOHNSON NW. Essential questions concerning periodontal diseases in HIV infection. Oral Dis 1997; 3: suppl. (1):S138-40.
31. LAMSTER JT, GRBIC JT, BUKLAN RS, MITCHELL-LEWIS D, REYNOLDS HS, ZAMBON JJ. Epidemiology and diagnosis of HIV-associated periodontal diseases. Oral Dis 1997; 3: suppl. (1):S141-8.
32. ROMEU J, BALAGU'E M, RUIZ L, et al. Value of HIV-1 viral load and CD4+ lymphocyte count as determinants of progression to AIDS and survival. Med Clin 1998; 110:761-7.
33. VLAHOV D, GRAHAM N, HOOVER D, et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA 1998; 279: 35-40.
34. PORTER SR, LUKER J, SCULLY C. Orofacial manifestations of a group of British patients infected with HIV-1. J Oral Pathol Med 1990; 19:477-81.
35. BARONE R, FICARRA G, GAGLIOTI D, et al. Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups. Oral Surg Oral Med Oral Pathol 1990; 69:169-73.
36. TUKUTUKU K, MUYEMBE-TAMFUM L, KAYEMBE K, et al. Prevalence of dental caries, gingivitis, and oral hygiene in hospitalized AIDS cases in Kinshasa, Zaire. J Oral Pathol Med 1990; 19:271-2
37. RAMIREZ V, GONZALES M, DE LA ROSA E, et al. Oral lesions in Mexican HIV-infected patients. J Oral Pathol Med 1990; 19:482-5.